Yiding Chen

Institute Of Urology & Anhui Province Key Laboratory Of Urological And Andrological Diseases Research And Medical Transformation
Hefei, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

ASO Visual Abstract: Exploring the Associations and Mechanisms Between Antihypertensive Drugs and Urologic Tumors-Insights from a Mendelian Randomization Study.

ASO Visual Abstract: Exploring the Associations and Mechanisms Between Antihypertensive Drugs and Urologic Tumors-Insights from a Mendelian Randomization Study.

Journal: Annals of surgical oncology

Published: May 27, 2026

ASO Author Reflections: From Blood Pressure Control to Tumor Risk: Genetic Clues Linking Antihypertensive Drug Targets to Urological Tumors.

ASO Author Reflections: From Blood Pressure Control to Tumor Risk: Genetic Clues Linking Antihypertensive Drug Targets to Urological Tumors.

Journal: Annals of surgical oncology

Published: April 13, 2026

A C57BL/6N mice model of CP/CPPS established by prostate antigen immunization with DPT and BCG co-administration.

A C57BL/6N mice model of CP/CPPS established by prostate antigen immunization with DPT and BCG co-administration.

Journal: Frontiers in immunology

Published: January 03, 2026

The viability of ABO-incompatible kidney transplants: a single-center cohort in China.

The viability of ABO-incompatible kidney transplants: a single-center cohort in China.

Journal: Frontiers in immunology

Published: November 16, 2025

Lower eGFR Associated With Decreased Total Testosterone in Males: Integrated Evidence From Cohorts to Real-World Data.

Lower eGFR Associated With Decreased Total Testosterone in Males: Integrated Evidence From Cohorts to Real-World Data.

Journal: Andrology

Published: November 11, 2025

Genetic and metabolomic pathways linking frailty, chronic kidney disease, and kidney failure: a Mendelian randomization and multi-omics analysis.

Genetic and metabolomic pathways linking frailty, chronic kidney disease, and kidney failure: a Mendelian randomization and multi-omics analysis.

Journal: Renal failure

Published: November 11, 2025

Prognostic and immunological implications of cathepsin Z overexpression in prostate cancer.

Prognostic and immunological implications of cathepsin Z overexpression in prostate cancer.

Journal: Frontiers in immunology

Published: April 26, 2025

Rare Multiple Brain Metastases Following Debulking Surgery and Androgen Deprivation Therapy in Aggressive Prostate Cancer-Case Report.

Rare Multiple Brain Metastases Following Debulking Surgery and Androgen Deprivation Therapy in Aggressive Prostate Cancer-Case Report.

Journal: Oncology research

Published: April 09, 2025

Exploring the Associations and Mechanisms Between Antihypertensive Drugs and Urological Tumors: Insights from a Mendelian Randomization Study.

Exploring the Associations and Mechanisms Between Antihypertensive Drugs and Urological Tumors: Insights from a Mendelian Randomization Study.

Journal: Annals of surgical oncology

Published: March 19, 2025

Comprehensive genomic insights into the genetic causality and comorbidity in urological cancers.

Comprehensive genomic insights into the genetic causality and comorbidity in urological cancers.

Journal: NPJ precision oncology

Published: December 20, 2024

IGF1R Promotes Th17/Treg Cell Development in Experimental Autoimmune Prostatitis.

IGF1R Promotes Th17/Treg Cell Development in Experimental Autoimmune Prostatitis.

Journal: Journal of inflammation research

Published: November 27, 2024

Sex hormones, blood metabolites and proteins mediating the causal associations between gut microbiota and prostatic diseases: evidences from Mendelian randomization study.

Sex hormones, blood metabolites and proteins mediating the causal associations between gut microbiota and prostatic diseases: evidences from Mendelian randomization study.

Journal: Prostate international

Published: October 14, 2024

Showing 1-12 of 21

Last Updated: 09/26/2026